Health Care
CONYERS, GA – Congressman Hank Johnson (GA-04) issued the following statement after closely monitoring the BioLab fire in conjunction with local, state and federal officials, meeting with affected residents and considering the plant’s safety record:
“As the number of people living in and around Conyers and the surrounding area continues to grow, this plant – which stores toxic chemicals – has become a threat to public health and should no longer be allowed to operate at its current location,” said Congressman Hank Johnson (GA-04).
CONYERS, GA – Congressman Hank Johnson (GA-04) issued the following statement on the latest information concerning the BioLab chemical fire that is affecting air quality in the Fourth Congressional District and beyond:
Lawmakers Encourage Expanded Medicare Beneficiary Vaccine Access
WASHINGTON, D.C. – Today, Congressman Hank Johnson (GA-04) and Nydia M. Velázquez (NY-07), co-chairs of the Hepatitis Caucus, sent a letter to Centers for Medicare & Medicaid Services urging them to expand access for seniors to the hepatitis B virus (HBV) vaccination.
During Black Maternal Health Week, Georgia Democrats led by Congressman Hank Johnson (GA-04) partnered with the Centers For Disease Control & Prevention (CDC). Together they released a video raising awareness of the fact that Black women in Georgia and nationwide are three times more likely to die from pregnancy than White women. Georgia has one of the highest maternal mortality rates in the country.
Congressman Honors Former Staff Member Diagnosed With Chordoma
WASHINGTON, D.C. — Congressman Hank Johnson (GA-04) announced today that he reintroduced a resolution to raise awareness of a rare form of cancer called chordoma after a former member of his staff was diagnosed with the rare condition last year.
Classified as a rare cancer of the spine and skull, chordoma is diagnosed in just 1,000 people worldwide every year, 300 of whom are in the United States.
WASHINGTON, D.C. — Congressman Hank Johnson (GA-04) and Congresswoman Lisa Blunt Rochester (DE-At Large) re-introduced legislation this week to recognize Oct. 17th as "National Vitiligo Awareness Day." The resolution honors courageous children and adults, who live with the autoimmune condition and must often overcome harassment and bullying.
NAIRHHA Day, September 9th, has been recognized in HIV/AIDS and Hepatitis communities but will now be recognized federally for the first time
Congressman Johnson (GA-04) visited the Centers for Disease Control and Prevention’s (CDC) Chamblee Campus as part of a tour of his district during the August work period. The visit included a campus tour and a roundtable discussion with CDC leadership and subject matter experts to discuss the agency’s work in sickle cell disease, hepatitis c and HIV/AIDS, including the important work being done in Georgia. The Congressman’s visit concluded with a tour of CDC’s environmental health laboratory.
Congressman Attends Roundtable Discussion on Accessing Treatments for Patients With Sickle Cell, Hep C & HIV With CDC Scientists
On Saturday, August 19 at Legacy Park in Decatur, Congressman Hank Johnson (GA-04) held his Ceremony of HOPE honoring the work of six local nonprofits, including Catholic Charities of Atlanta, Friends of Disabled Adults & Children (FODAC), the Women’s Resources Center to End Violence Against Women, the Rockdale Coalition for Children & Families, Newton Mentoring, Inc., and Newton County Historical Committee on Black Preservation.
Congressman Honors Service in Our Communities, Local Student With Congressional Award
DECATUR – On Saturday, August 19 at Legacy Park in Decatur, Congressman Hank Johnson (GA-04) held his Ceremony of HOPE honoring the work of six local nonprofits.
CMS will host a series of public engagement events this spring as part of the Medicare Drug Price Negotiation Program. The virtual public engagement events will provide an opportunity for patients, beneficiaries, caregivers, consumer and patient organizations, and other interested parties, such as clinicians and researchers, to share input relevant to drugs selected for the second cycle of negotiations.